vimarsana.com

Page 46 - ஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Why Covaxin being manufactured only at pvt institute? Madras HC asks Centre

Why Covaxin being manufactured only at pvt institute? Madras HC asks Centre ANI | Updated: May 08, 2021 00:44 IST Madurai (Tamil Nadu) [India], May 8 (ANI): The Madurai Bench of Madras High Court on Friday questioned the Central government why Covaxin, the vaccine against COVID-19 which was developed with the assistance of the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV), has been manufactured only at a private institute. The court asked the Centre to explain the amount incurred by the government to procure COVID vaccines and what steps have been taken to revive the vaccine institutes. The Madurai Bench of Madras High Court was also hearing a Public Interest Litigation (PIL) seeking direction to manufacture Covaxin in the Chengalpet HLL unit.

Open up licensing to develop vaccines and accelerate vaccination drive, demand medical experts

Companies other than Bharat Biotech must be given contracts to manufacture the indigenously developed Covaxin in bulk. This is the time to open licensing to any company that wants to produce vaccines and for anyone who wants to take a jab, per doctors.

Ocugen to seek emergency-use nod for Covaxin in US market - The Hindu BusinessLine

Ocugen to seek emergency-use nod for Covaxin in US market May 04, 2021 Covaxin demonstrates potential effectiveness against different variants, says study Ocugen, the US partner of Bharat Biotech for its Covid-19 vaccine Covaxin, is set to seek the US Food and Drug Administration’s nod for emergency-use authorisation of the vaccine in the US market. The Ocugen team has submitted a comprehensive drug master file with the FDA, and is currently diligently preparing the EUA application, according to Shankar Musunuri, Chairman of the Board, CEO and and co-founder of Ocugen. In February, Hyderabad-based Bharat Biotech and Ocugen entered into a pact, according to which the latter will co-develop, supply, and commercialise Covaxin.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.